科学家们发现“30%-40%乳腺癌存活者表达乳腺癌相关基因，这些基因可能是这些患者基因靶向治疗最大的靶标”。
Scientists have discovered a breast cancer gene 30% to 40% of all breast cancers need to survive, offering what could be the biggest gene target yet for "smart bombs" to treat such tumours.
此外，发现用于治疗HER 2阳性乳腺癌的药物赫赛汀，能够靶向和摧毁癌症干细胞。
Further, the drug Herceptin, which is used to treat HER2-positive breast cancer, was found to target and destroy the cancer stem cells.
阻断这些细胞因子信号，研究人员希望能通过靶向肿瘤干细胞群，成功地提供一种更有效的乳腺癌治疗手段。
By blocking these cytokine signals, researchers hope that they can successfully target the cancer stem cell population providing a more effective treatment for breast cancer.
单克隆抗体有高度特异性，探索乳腺癌的抗体靶向治疗有重要的临床价值。
Monoclonal antibody-based targeted treatment for breast cancer offers a promising approach for clinical breast cancer therapy.
这些结果表明，AR可为预测ER阳性乳腺癌内分泌疗效的附加指标，以及ER阴性肿瘤靶向治疗的候选靶点。
These results suggest that AR could be an additional marker for endocrine responsiveness in ER-positive cancers and a candidate for therapeutic targeting of ER-negative tumors.
本发明具有作为乳腺癌靶向性基因治疗的特异性载体的潜在临床应用价值。
The invention as a specificity carrier of the mammary cancer-targeting genetic therapy has potential clinic application value.
本发明具有作为乳腺癌靶向性基因治疗的特异性载体的潜在临床应用价值。
The invention as a specificity carrier of the mammary cancer-targeting genetic therapy has potential clinic application value.
应用推荐